CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-06 | Molineaux Christopher P. Director | Option exercise · Restricted Stock Units | −4,793 | 0 | ||
| 2025-06-05 | SCHIFF ANDREW N Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | SCHIFF ANDREW N Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-06-05 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | MILANO VINCENT Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-06-05 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | Mehra Anand Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-06-05 | Humphries William D. Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | Humphries William D. Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-06-05 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | GOWEN MAXINE Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-06-05 | Molineaux Christopher P. Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2025-06-05 | Molineaux Christopher P. Director | Grant or award · Restricted Stock Units | +11,580 | 11,580 | ||
| 2025-05-01 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Restricted Stock Units | +145,500 | 145,500 | ||
| 2025-05-01 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +510,000 | 510,000 | ||
| 2025-05-01 | Walker Neal CEO | Option exercise | +9,467 | 1,482,799 | ||
| 2025-05-01 | Walker Neal CEO | Shares withheld for taxes | −2,975 | $1.38 | $4K | 1,479,824 |
| 2025-05-01 | Walker Neal CEO | Option exercise · Restricted Stock Units | −9,467 | 0 | ||
| 2025-04-01 | Walker Neal CEO | Option exercise | +9,467 | 1,476,374 | ||
| 2025-04-01 | Walker Neal CEO | Shares withheld for taxes | −3,042 | $1.48 | $5K | 1,473,332 |
Page 6 of 34 · 680 trades